The global Medical Dry Powder Inhalers (DPIs) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Medical Dry Powder Inhalers (DPIs) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Medical Dry Powder Inhalers (DPIs), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Dry Powder Inhalers (DPIs) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Medical Dry Powder Inhalers (DPIs) total production and demand, 2018-2029, (K Units)
Global Medical Dry Powder Inhalers (DPIs) total production value, 2018-2029, (USD Million)
Global Medical Dry Powder Inhalers (DPIs) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Dry Powder Inhalers (DPIs) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Medical Dry Powder Inhalers (DPIs) domestic production, consumption, key domestic manufacturers and share
Global Medical Dry Powder Inhalers (DPIs) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Medical Dry Powder Inhalers (DPIs) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Dry Powder Inhalers (DPIs) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Medical Dry Powder Inhalers (DPIs) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Dry Powder Inhalers (DPIs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Medical Dry Powder Inhalers (DPIs) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Medical Dry Powder Inhalers (DPIs) Market, Segmentation by Type
Single Dose
Multi Dose
Global Medical Dry Powder Inhalers (DPIs) Market, Segmentation by Application
Asthma
COPD
Others
Companies Profiled:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Key Questions Answered
1. How big is the global Medical Dry Powder Inhalers (DPIs) market?
2. What is the demand of the global Medical Dry Powder Inhalers (DPIs) market?
3. What is the year over year growth of the global Medical Dry Powder Inhalers (DPIs) market?
4. What is the production and production value of the global Medical Dry Powder Inhalers (DPIs) market?
5. Who are the key producers in the global Medical Dry Powder Inhalers (DPIs) market?
6. What are the growth factors driving the market demand?
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Supply Summary
1.1 Medical Dry Powder Inhalers (DPIs) Introduction
1.2 World Medical Dry Powder Inhalers (DPIs) Supply & Forecast
1.2.1 World Medical Dry Powder Inhalers (DPIs) Production Value (2018 & 2022 & 2029)
1.2.2 World Medical Dry Powder Inhalers (DPIs) Production (2018-2029)
1.2.3 World Medical Dry Powder Inhalers (DPIs) Pricing Trends (2018-2029)
1.3 World Medical Dry Powder Inhalers (DPIs) Production by Region (Based on Production Site)
1.3.1 World Medical Dry Powder Inhalers (DPIs) Production Value by Region (2018-2029)
1.3.2 World Medical Dry Powder Inhalers (DPIs) Production by Region (2018-2029)
1.3.3 World Medical Dry Powder Inhalers (DPIs) Average Price by Region (2018-2029)
1.3.4 North America Medical Dry Powder Inhalers (DPIs) Production (2018-2029)
1.3.5 Europe Medical Dry Powder Inhalers (DPIs) Production (2018-2029)
1.3.6 China Medical Dry Powder Inhalers (DPIs) Production (2018-2029)
1.3.7 Japan Medical Dry Powder Inhalers (DPIs) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medical Dry Powder Inhalers (DPIs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medical Dry Powder Inhalers (DPIs) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World Medical Dry Powder Inhalers (DPIs) Demand (2018-2029)
2.2 World Medical Dry Powder Inhalers (DPIs) Consumption by Region
2.2.1 World Medical Dry Powder Inhalers (DPIs) Consumption by Region (2018-2023)
2.2.2 World Medical Dry Powder Inhalers (DPIs) Consumption Forecast by Region (2024-2029)
2.3 United States Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
2.4 China Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
2.5 Europe Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
2.6 Japan Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
2.7 South Korea Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
2.8 ASEAN Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
2.9 India Medical Dry Powder Inhalers (DPIs) Consumption (2018-2029)
3 World Medical Dry Powder Inhalers (DPIs) Manufacturers Competitive Analysis
3.1 World Medical Dry Powder Inhalers (DPIs) Production Value by Manufacturer (2018-2023)
3.2 World Medical Dry Powder Inhalers (DPIs) Production by Manufacturer (2018-2023)
3.3 World Medical Dry Powder Inhalers (DPIs) Average Price by Manufacturer (2018-2023)
3.4 Medical Dry Powder Inhalers (DPIs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medical Dry Powder Inhalers (DPIs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medical Dry Powder Inhalers (DPIs) in 2022
3.5.3 Global Concentration Ratios (CR8) for Medical Dry Powder Inhalers (DPIs) in 2022
3.6 Medical Dry Powder Inhalers (DPIs) Market: Overall Company Footprint Analysis
3.6.1 Medical Dry Powder Inhalers (DPIs) Market: Region Footprint
3.6.2 Medical Dry Powder Inhalers (DPIs) Market: Company Product Type Footprint
3.6.3 Medical Dry Powder Inhalers (DPIs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Medical Dry Powder Inhalers (DPIs) Production Value Comparison
4.1.1 United States VS China: Medical Dry Powder Inhalers (DPIs) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Medical Dry Powder Inhalers (DPIs) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Medical Dry Powder Inhalers (DPIs) Production Comparison
4.2.1 United States VS China: Medical Dry Powder Inhalers (DPIs) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medical Dry Powder Inhalers (DPIs) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Medical Dry Powder Inhalers (DPIs) Consumption Comparison
4.3.1 United States VS China: Medical Dry Powder Inhalers (DPIs) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Medical Dry Powder Inhalers (DPIs) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Medical Dry Powder Inhalers (DPIs) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Medical Dry Powder Inhalers (DPIs) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medical Dry Powder Inhalers (DPIs) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Medical Dry Powder Inhalers (DPIs) Production (2018-2023)
4.5 China Based Medical Dry Powder Inhalers (DPIs) Manufacturers and Market Share
4.5.1 China Based Medical Dry Powder Inhalers (DPIs) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medical Dry Powder Inhalers (DPIs) Production Value (2018-2023)
4.5.3 China Based Manufacturers Medical Dry Powder Inhalers (DPIs) Production (2018-2023)
4.6 Rest of World Based Medical Dry Powder Inhalers (DPIs) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Medical Dry Powder Inhalers (DPIs) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medical Dry Powder Inhalers (DPIs) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Medical Dry Powder Inhalers (DPIs) Production (2018-2023)
5 Market Analysis by Type
5.1 World Medical Dry Powder Inhalers (DPIs) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Single Dose
5.2.2 Multi Dose
5.3 Market Segment by Type
5.3.1 World Medical Dry Powder Inhalers (DPIs) Production by Type (2018-2029)
5.3.2 World Medical Dry Powder Inhalers (DPIs) Production Value by Type (2018-2029)
5.3.3 World Medical Dry Powder Inhalers (DPIs) Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Medical Dry Powder Inhalers (DPIs) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Asthma
6.2.2 COPD
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Medical Dry Powder Inhalers (DPIs) Production by Application (2018-2029)
6.3.2 World Medical Dry Powder Inhalers (DPIs) Production Value by Application (2018-2029)
6.3.3 World Medical Dry Powder Inhalers (DPIs) Average Price by Application (2018-2029)
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Details
7.1.2 GlaxoSmithKline Major Business
7.1.3 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Product and Services
7.1.4 GlaxoSmithKline Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 GlaxoSmithKline Recent Developments/Updates
7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Medical Dry Powder Inhalers (DPIs) Product and Services
7.2.4 AstraZeneca Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Details
7.3.2 Boehringer Ingelheim Major Business
7.3.3 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Product and Services
7.3.4 Boehringer Ingelheim Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Chiesi
7.4.1 Chiesi Details
7.4.2 Chiesi Major Business
7.4.3 Chiesi Medical Dry Powder Inhalers (DPIs) Product and Services
7.4.4 Chiesi Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Chiesi Recent Developments/Updates
7.4.6 Chiesi Competitive Strengths & Weaknesses
7.5 Cipla
7.5.1 Cipla Details
7.5.2 Cipla Major Business
7.5.3 Cipla Medical Dry Powder Inhalers (DPIs) Product and Services
7.5.4 Cipla Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Cipla Recent Developments/Updates
7.5.6 Cipla Competitive Strengths & Weaknesses
7.6 3M
7.6.1 3M Details
7.6.2 3M Major Business
7.6.3 3M Medical Dry Powder Inhalers (DPIs) Product and Services
7.6.4 3M Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 3M Recent Developments/Updates
7.6.6 3M Competitive Strengths & Weaknesses
7.7 Hovione
7.7.1 Hovione Details
7.7.2 Hovione Major Business
7.7.3 Hovione Medical Dry Powder Inhalers (DPIs) Product and Services
7.7.4 Hovione Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hovione Recent Developments/Updates
7.7.6 Hovione Competitive Strengths & Weaknesses
7.8 Mannkind
7.8.1 Mannkind Details
7.8.2 Mannkind Major Business
7.8.3 Mannkind Medical Dry Powder Inhalers (DPIs) Product and Services
7.8.4 Mannkind Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Mannkind Recent Developments/Updates
7.8.6 Mannkind Competitive Strengths & Weaknesses
7.9 Mylan
7.9.1 Mylan Details
7.9.2 Mylan Major Business
7.9.3 Mylan Medical Dry Powder Inhalers (DPIs) Product and Services
7.9.4 Mylan Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mylan Recent Developments/Updates
7.9.6 Mylan Competitive Strengths & Weaknesses
7.10 Novartis
7.10.1 Novartis Details
7.10.2 Novartis Major Business
7.10.3 Novartis Medical Dry Powder Inhalers (DPIs) Product and Services
7.10.4 Novartis Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis Recent Developments/Updates
7.10.6 Novartis Competitive Strengths & Weaknesses
7.11 Schering/Merck
7.11.1 Schering/Merck Details
7.11.2 Schering/Merck Major Business
7.11.3 Schering/Merck Medical Dry Powder Inhalers (DPIs) Product and Services
7.11.4 Schering/Merck Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Schering/Merck Recent Developments/Updates
7.11.6 Schering/Merck Competitive Strengths & Weaknesses
7.12 Teva
7.12.1 Teva Details
7.12.2 Teva Major Business
7.12.3 Teva Medical Dry Powder Inhalers (DPIs) Product and Services
7.12.4 Teva Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Teva Recent Developments/Updates
7.12.6 Teva Competitive Strengths & Weaknesses
7.13 Vectura
7.13.1 Vectura Details
7.13.2 Vectura Major Business
7.13.3 Vectura Medical Dry Powder Inhalers (DPIs) Product and Services
7.13.4 Vectura Medical Dry Powder Inhalers (DPIs) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Vectura Recent Developments/Updates
7.13.6 Vectura Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Medical Dry Powder Inhalers (DPIs) Industry Chain
8.2 Medical Dry Powder Inhalers (DPIs) Upstream Analysis
8.2.1 Medical Dry Powder Inhalers (DPIs) Core Raw Materials
8.2.2 Main Manufacturers of Medical Dry Powder Inhalers (DPIs) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Medical Dry Powder Inhalers (DPIs) Production Mode
8.6 Medical Dry Powder Inhalers (DPIs) Procurement Model
8.7 Medical Dry Powder Inhalers (DPIs) Industry Sales Model and Sales Channels
8.7.1 Medical Dry Powder Inhalers (DPIs) Sales Model
8.7.2 Medical Dry Powder Inhalers (DPIs) Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
*If Applicable.